Change in topoisomerase 1 (Top1) positive circulating tumor cells impacts overall survival in patients with advanced breast cancer after treatment with etirinotecan pegol.

Auteurs : Rugo HS, Cortes J, Awada A, OShaughnessey J, Twelves CJ, Im SA, Hannah A, Lu L, Sy S, Caygill K, Zajchowski DA, Davis DW, Tagliaferri MA, Hoch U, Perez EA
Année : 2018
Journal : Clin Cancer Res
Volume : 24(14)
Pages : 3348-3357